Abridge, a generative AI platform serving the healthcare industry, has secured a $250 million Series D investment, co-led by Elad Gil and IVP. The raise coincides with the company’s milestone of deploying its platform with more than 100 major health systems.
Alongside the funding round, Abridge announced the launch of its new contextual reading engine, an AI architecture that works to generate comprehensive, billable notes at the point of care. It integrates data from past patient encounters, health system-specific revenue cycle guidelines and clinician documentation preferences. The solution detects and groups medical problems and integrates medical orders into electronic health records to streamline clinical and financial workflows.
Abridge’s technology recently extended into health systems such as Duke Health, Johns Hopkins, Mayo Clinic and UNC Health. Its latest funding investment will enable the company to advance its solution, fueling further AI capability development and commercial growth to support broader applications.
